| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 5e-05 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |